To assess the feasibility of using the renin promoter for expressing Cre recombinase in JG cells only, we generated 5 independent transgenic mouse lines (designated hRen-Cre) expressing Cre recombinase under control of a 12.2 kb human renin promoter. In the kidneys of adult mice Cre mRNA (RT-PCR) was found in the renal cortex with Cre protein (immunohistochemistry) being localized in afferent arterioles, and to a lower degree in interlobular arteries. Cre mRNA levels were regulated in a renin-typical fashion by changes in oral salt intake, water restriction, or isoproterenol infusion, indicating the presence of key regulatory elements within 12.2 kb of the 5'-flanking region of the human renin gene. hRen-Cre mice were interbred with both the ROSA26-EGFP and ROSA26-lacZ reporter strains to assess renin promoter activity from Cre-mediated excision of a floxed stop-cassette and subsequent EGFP and β-gal detecetion. In adult mice, β-gal staining and EGFP was observed in afferent arterioles and interlobular arteries overlapping with Cre protein expression. In addition, intense β-gal staining was found in cortical and medullary collecting ducts where Cre expression was minimal. In embryonic kidneys, β-gal staining was detected in the developing collecting duct system beginning at day E12, showing substantial activity of the human renin promoter in the branching ureteric bud. Our data indicate that besides its well known activity in JG cells and renal vessels the human renin promoter is transiently active in the collecting duct system during kidney development complicating the use of this approach for JG cell-specific excision of floxed targets.
Introduction
The renin-angiotensin system plays a key role in the regulation of body fluid volume and arterial blood pressure. In general, the production and release of the proteolytic enzyme renin by juxtaglomerular (JG) cells is rate-limiting for the generation of the bioactive end-product angiotensin II. Thus, an assessment of the response of the renin-angiotensin system to physiological and pathological challenges requires an understanding of the signaling mechanisms regulating the synthesis and secretion of renin. Investigations of the pathways affecting renin release by JG cells would be greatly aided by cell-specific deletions of individual signaling components. A possible first step to achieve such spatial control of gene expression in JG cells is the identification of a cell-specific promoter that can be utilized to express Cre recombinase in this cell type.
In the adult organism, renin is a rather specific marker of JG cells (29, 30) .
Although the enzyme can also be found in low levels in other locations, the renin promoter would therefore appear to be a good candidate to direct robust and selective expression of Cre recombinase to JG cells. Expression of β-gal in a transgenic mouse in which the LacZ gene was placed under the control of a 12.2 kb fragment of the human renin promoter has recently been shown to mirror the localization of expression of endogenous murine renin (6) suggesting that major regulatory sequences in the promoter responsible for the specific local activity of the promoter in vivo reside within this fragment. In the present experiments, we have therefore used this human renin promoter in a construct containing Cre recombinase to generate transgenic mice with JG cellspecific expression of the enzyme.
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The primary aim of the present study was to investigate whether Cre-recombinase expression and enzyme activity driven by the renin promoter (Ren-Cre) is confined to JG cells so that it could be used for cell-specific excision of floxed targets. This aim was pursued by generating a mouse strain carrying a human renin promoter/Cre transgene (Ren-Cre mouse), and by crossing this line with the ROSA26-lacZ reporter strain in which the expression of the LacZ reporter gene in all cells is suppressed by a floxed stop cassette (12, 28) . This cross also enabled us to track the activity of the human renin promoter throughout the ontogeny of the mouse. In adult offspring of this cross we observed the expected Cre-activity and the resulting expression of the reporter gene in JG cells of the juxtaglomerular apparatus. However, we also obtained evidence for the presence of Cre-recombinase activity in the renal medulla of the developing embryo, and an associated expression of the reporter gene in collecting duct cells of the adult. Since in the adult no Cre-recombinase activity was observed in the medulla, it appears that Cremediated recombination is an early event causing deletion of the floxed stop codon in collecting duct progenitor cells and in all cells derived from this cell lineage.
.
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Methods
Generation of transgenic mice. For the generation of transgenic mice expressing Cre recombinase under the control of the human renin promoter, a construct was designed consisting of a 12.2 kb fragment of the human renin promoter and a Cre expression cassette, as shown in Fig. 1 . In brief, a NotI / AgeI fragment consisting of a matrix attachment region (MAR) and a 12.2 kb fragment of the human renin promoter was removed from the vector pSG12000 (6) and inserted upstream of the Cre coding sequence in pBS185 (gift from B. Sauer) resulting in the transgene vector hRen-Cre. The original pSG12000 vector was generated by fusion of the 5' matrix attachment region of the lysozyme gene (spanning from -11.7 kb to -8.8 kb upstream of the lysozyme gene) to a 12.2 kb human renin promoter as a BamHI/SpeI fragment (6). The lacZ reporter gene vector pSG consisting of p46.21D (4), modified by insertion of a NotI, BamHI, SpeI, PacI, SmaI, PstI, XhoI linker, served as the backbone vector for pSG12000. For DNA microinjections, the plasmid backbone of hRen-Cre was removed and the construct DNA consisting of MAR, human renin promoter and Cre expression cassette was purified by gel electrophoresis, recovered and re-purified using QiaEx II (Qiagen) and finally diluted to a concentration of 2.5 ng/µl. The correctness of the plasmid sequence was confirmed by sequencing. One-cell embryos were harvested from superovulated female mice of the FVB strain. The purified construct DNA was then injected into one of the pronuclei of one-cell embryos and embryos were transferred to foster mothers according to standard protocols. Five independent lines with stable integration of the transgene in the genome were established. The presence of the transgene was determined by PCR using the 6 primers 5'-aggtgtagagaaggcacttagc-3' (sense) and 5'-ctaatcgccatcttccagcagg-3' (antisense).
Detection of Cre mRNA and murine renin mRNA. Total RNA was isolated from various organs using TRIzol reagent (Gibco-BRL; Life Technologies Inc.). The cDNA was synthesized by MMLV reverse transcriptase (Superscript, Invitrogen). Remaining genomic DNA was digested with RNase-free DNase (Roche), and PCR was performed without RT to test for the efficiency of the digestion. For quantification of Cre and renin mRNA expression real time RT-PCR was performed using the light-cycler system (Roche) with β-actin as a control.
Crossing of the hRen-Cre to ROSA26 reporter mice. To detect the presence and localization of Cre activity, a measure of the activity of the human renin promoter, hRenCre mice were crossed to the reporter strains ROSA26-lacZ and ROSA26-EGFP (Jackson Laboratories). Cre-positive offspring was used for the localization of β-gal activity and EGFP immunohistochemistry, respectively. Cre-negative offspring served as negative controls to check for unspecific staining. For the detection of the activity of the human renin promoter in embryonic tissues, male and female mice were set up for breeding in the afternoon, and females were controlled for the presence of a vaginal plug the next morning, designated embryonic day 1 (E1). Embryos were removed from pregnant females at given time points. Whole embryos were fixed by incubation in 3% paraformaldehyde dissolved in PBS for 3 hrs at 4ºC followed by incubation in 330 mOsm sucrose overnight. Cryostat sections (10 µm) were then used for the detection of β-galactosidase (β-gal) activity.
Cre, EGFP and aquaporin-2 immunohistochemistry. The expression of Cre protein was localized by immunohistochemistry. Since the detection of EGFP in positive reporter mice turned out to be unreliable in our hands, EGFP was also detected by immunohistochemistry. In brief, mice were anesthetized and kidneys were fixed in situ by consecutive perfusion with 330 mOsm sucrose/PBS (pH 7.4), followed by 3% paraformaldehyde dissolved in PBS as described (31) . Immunolabeling was performed on 5 µm cryostat sections. After blocking with 5% skim milk in PBS, pH 7.4, sections were incubated with the anti Cre, anti EGFP or anti aquaporin-2 (Dianova) antibody overnight at 4ºC, followed by incubation with a fluorescent secondary antibody. mM MgCl 2 , 20 mM NaCl ) for 5 min, X-Gal (1 mg/ml) was applied and sections were incubated for 4 hrs in a moist chamber at room temperature. After removal of the staining solution sections were counter-stained with a nucleus staining (Kernechtrot, Merck).
Detection of β-galactosidase
Animal experiments.
All animal experiments were conducted according to the NIH guidelines for the care and use of animals in research. Male hRen-Cre mice aged 7-8 weeks were subjected to the following treatments (n=6 for each experimental group): 1) Control group: mice were fed a standard rodent chow (0.4% NaCl [w/w]) and had free access to tap water; 2) salt-deficient group: mice were fed a low salt diet (0.02% NaCl [w/w]) for 7 days and received the ACE inhibitor enalapril (10 mg/kg/d) via the drinking water; 3) salt-loaded group: mice were fed a high salt diet (8% NaCl [w/w]) for 7 days 8 and received tap water as drinking fluid; 4) water restriction: mice were fed a normal salt diet (0.4% NaCl [w/w]), and the drinking bottle was removed for a period of 36 hrs; 5) isoproterenol group: a continuous infusion of isoproterenol (10 mg/kg/d) was administered for 48 hr via subcutaneously implanted osmotic minipumps (Alzec) (13) .
Mice were fed a standard rodent chow and had free access to tap water.
After the respective treatment mice were anesthetized with isoflurane and euthanized by cervical dislocation. The kidneys were removed and frozen in liquid nitrogen. Organs were stored at -80ºC before isolation of RNA, as described above.
Statistical analysis. Multiple groups were analyzed with ANOVA followed by Bonferroni post-test. A p-value < .05 was considered significant.
Results
Cre expression in the adult kidney. In the kidneys of adult mice, expression of Cre protein determined by immunohistochemistry was restricted to the renal cortex. As can be seen in Figs We then determined whether the activity of the human renin promoter as assessed by expression of Cre recombinase, and of the endogenous mouse renin promoter as assessed by expression of renin were modulated to a comparable extent by manipulations known to activate or suppress the endogenous renin system. As shown in Fig. 3 , administration of a high salt diet led to a suppression of renin and Cre mRNA levels to 48 ± 5 and 61 ± 8% of the respective control values (p= .01 and .02 vs. control). Conversely, salt restriction in combination with ACE inhibition stimulated the expression of both endogenous renin and Cre mRNA to 650 ± 130 and 980 ± 320% of control (p<.01 vs.
control for both renin and Cre mRNA). For both maneuvers, the relative change in Cre and in mouse renin mRNA levels were not significantly different. Water deprivation for 36 hrs also led to a parallel stimulation of the expression of murine renin and Cre mRNA (to 470 ± 111 and 211 ± 89% of control), although in this case the relative increase in Cre mRNA levels over control was significantly lower than that of murine renin mRNA (p=.021 vs. renin mRNA). To investigate the responsiveness of renin expression to an increase in intracellular cAMP, a known stimulator of renin promoter activity (7,11,17), mice were infused with isoproterenol (10 mg/kg/d) via osmotic minipumps for 48 hours.
Chronic isoproterenol application stimulated endogenous renin mRNA expression to 250 ± 50% of control (p=. 013 vs. control). Cre mRNA levels were increased significantly to 180 ± 32% (p=.03 vs. control), with relative increases being significantly lower compared to endogenous renin mRNA levels (p=.01). Stimulation of Cre mRNA under all conditions was restricted to the renal cortex whereas Cre mRNA in the renal medulla remained statistically undetectable. Taken together, the parallel and quantitatively comparable regulation of endogenous renin mRNA expression and Cre mRNA suggest that key regulatory elements in the 12.2 kb fragment of the human renin promoter are functional in the mouse model.
Cre activity in the adult mouse. To track the activity of the human renin promoter throughout the ontogeny of the mouse, Cre activity was determined in offspring of crosses of hRen-Cre and ROSA26-lacZ or ROSA26-EGFP reporter strains. β-gal or EGFP signals are expected to be positive in cells derived from progenitors in which Cremediated recombination has occurred at any stage of development (12, 28) . In the adult mouse, intense β-gal staining was found in the juxtaglomerular portion of the afferent arterioles and in interlobular arteries, thus overlapping with Cre protein expression (Fig.   4) . Similar results were obtained for the EGFP-reporter line (not shown). Some labeled cells were also found scattered throughout the glomerular mesangium (Fig. 4C) .
Unexpectedly, however, intense β-gal staining was consistently observed in the medulla of the adult kidney with the most intense β-gal staining being present in medullary segments of collecting ducts (Fig. 4) . Since Cre protein expression was undetectable in the medulla of the adult kidney, this observation indicates substantial medullary activity of the human renin promoter before adulthood. Co-staining with an anti-aquaporin-2 antibody revealed colocalization of AQP-2 and β-gal activity in most, but not all collecting duct cells (Fig. 4G) . Cre-negative reporter offspring served as controls; no unspecific β-gal background staining was detected ( fig. 4H, I ). These studies indicate that Cre activity was sufficient to delete the floxed stop cassette of the reporter strain in collecting duct progenitor cells.
As shown in Fig. 5 , extrarenal β-gal staining was restricted to the adrenal cortex, testis, aorta, single cerebral cells, and at very low levels to large vessels in the liver. In all of these organs Cre mRNA expression in the adult mouse was very low compared to the kidney (not shown) suggesting activity of the human renin promoter confined to embryonic development. Thus, the activity of the human renin promoter in the adult mouse is restricted to renin-typical expression sites, but as detected by Cre activity in reporter mice, the human renin promoter is active in the renal collecting duct during kidney development and appears to become largely silent at this site in the adult kidney.
Cre activity during embryonic development. In view of the intense β-gal staining in the collecting ducts of the adult kidney despite absence of Cre expression, we assessed β-gal staining as a surrogate marker of human renin promoter activity during embryonic development. Embryos were harvested at E12, E14, E16 and P1 and the localization of β-gal staining in the reporter strain was determined. As shown in Fig. 6 , in the embryonic kidney the human renin promoter is active in the developing collecting duct system including the branching tip of the collecting duct ampullae. In addition, β-gal positive cells were also detected in large renal vessels (Fig. 6E) . Intense activity of the human renin promoter was also observed in the adrenal gland cortex (Fig. 6F, and Fig. 7 showing a cross-section of the whole embryo at day E 14). In embryos from Cre negative mice serving as controls, no considerable background staining was observed (not shown).
These observations confirm our notion that the human renin promoter is active in the branching ureteric bud system during embryogenesis, but that it turns largely silent during postnatal life.
Discussion
The aim of the present study was to assess the feasibility of using a 12. (19) , and rendering it unlikely that the expression pattern of Cre recombinase was substantially influenced by the integration site into the mouse genome. Thus, these data confirm the previous conclusion that 12.2 kb of the human renin promoter are sufficient to target the expression of different transgenes to renin-typical sites (6) . It appears that the regulatory sequences which might be present in introns or the 3'-UTR of the renin gene (1, 35) are not crucial to target the expression of the gene to its typical localization within the kidney. In earlier studies, constructs containing less than 5 kb of the human renin promoter failed to induce significant expression of luciferase or SV40 T-antigen transgenes in mice (26) . On the other hand, 4 kb of mouse renin 5'-flanking sequence were shown to be adequate to direct the expression of green fluorescent protein to JG cells (9) .
To address the question whether key regulatory elements for the modulation of the activity of the human renin promoter were functional in the 12.2 kb fragment of the human renin promoter in the in vivo mouse model, we examined the effect of known inducers of renin expression on mRNA levels of Cre recombinase. We found that the activity of the human renin promoter as assessed by Cre expression was altered in parallel with the expression of the endogenous renin gene under a high salt diet, during a low salt diet in combination with ACE inhibition, during water restriction, and after isoproterenol infusion. This is in agreement with the earlier observation that the expression of the LacZ gene under control of the same human renin promoter was augmented in parallel to renin in mice treated with furosemide and a low salt diet, and in the clipped kidneys of mice with renal artery stenosis (6) . In general, the expression of Cre recombinase and of mouse 14 renin were regulated in parallel and to about the same extent. Nevertheless, mRNA levels of Cre recombinase during water restriction and isoproterenol administration were significantly lower compared to levels of endogenous renin mRNA. Both of these maneuvers are expected to increase cAMP levels in juxtaglomerular cells by activation of the sympathetic nervous system and by direct activation of β-receptors, respectively. It is conceivable that differences in steady-state levels of renin and Cre mRNA are a reflection of different effects of the cAMP/PKA pathway in stabilizing respective mRNAs. While there is good evidence that cAMP prolongs the half life of renin mRNA (1, 2) , there is currently no reason to assume that the stability of Cre mRNA, as a readout of the activity of the human renin promoter, is similarly regulated. These data appear to support the functional relevance of the cAMP responsive elements shown to be importantly involved in the regulation of the murine Ren1c promoter (11, 17) , and -based on homology comparisons (14) -presumably also of the human renin promoter. Transgenic mice with mutations in presumed regulatory elements of the human renin promoter detected by in vitro studies therefore may prove to be valuable tools to investigate the function of the human renin promoter under in vivo conditions. While measurements of Cre expression in adult mice provide a measure of the persistence of the human renin promoter activity, this approach does not necessarily provide insights into renin promoter activity during development. Since renin expression shows a wider expression pattern in embryonic than adult kidneys, it is possible that Cremediated excision of floxed targets may take place in cells in which the renin promoter is transiently active during development; this recombination could then be transmitted to daughter cells in the same lineage (12, 28) . Observations in offspring of crosses of the hRen-Cre transgenic mice with the ROSA26-lacZ reporter strain indicate that this is in fact the case. It is a striking finding in our study that robust and consistent β-gal staining was found in the renal medulla with a cellular localization in collecting ducts (Fig. 4) .
Since significant levels of Cre recombinase mRNA and Cre recombinase activity were not detectable in the renal medulla of adult mice, it is likely that recombination with excision of the floxed stop codon has taken place in embryonic life. Since the renin promoter-driven activation of Cre causes a recombination at the DNA level, all cells of the respective cell lineage are expected to be lacZ positive, even if the human renin promoter turns silent in postnatal life (12, 25) . In fact, β-gal staining reflecting activity of the human renin promoter was noted in the developing collecting duct system of the embryonic kidney beginning as early as day E12. Previous studies of renin-driven expression of reporter genes in transgenic mice have not reported measurable promoter activity in medullary tissue of either embryonic or adult kidneys. Nevertheless, GFP expression under control of a 4 kb renin promoter was found during embryogenesis in the Wolffian duct, the origin of the ureteric bud that gives rise to the collecting duct system (9) . Similarly, a recent in vitro study showed the expression of renin in ureteral branches of kidney explants from E14 rat embryos (16) . Activity of the human renin promoter in a similar localization in our studies could explain the β-gal staining found in the collecting duct system in later stages of kidney development. Furthermore, GFP expression under the control of a 4 kb mouse renin promoter was reported to be most pronounced in "cells with epithelial morphology" although the localization of these cells was considered to be vascular (9) . In another study in which GFP expression was under the control of the endogenous mouse Ren1d promoter, the focus has been exclusively on vascular expression, and no comment, positive or negative, can be found related to extravascular expression in the developing kidney (18) . Similarly, in a recent study in which Cre expression was under the control of the endogenous Ren1d promoter, analysis of a cross with ROSA26 reporter mice revealed a similar pattern of Cre activity in the renal cortex including the renal vasculature and single mesangial cells (25) . Again, the focus was on Cre expression in the renal cortex and no data are given regarding medullary Cre activity (25) . Although renin expression is absent or very low in the medulla of adult kidneys, renin expression was recently reported to be induced in the collecting ducts of rats under conditions of high circulating angiotensin II levels (20, 21) . Renin mRNA and protein were also found to be expressed at low levels in the connecting tubule of mice during salt restriction (22, 23) . The presence of renin mRNA in the medulla at least under some circumstances and our evidence for transient medullary activity of the renin promoter during development would add a mechanistic aspect to the notion that angiotensin II may be involved in kidney development and in particular in the morphogenesis of the branching ureteric bud (8) . In agreement with this concept, RAS-deficient mouse models are consistently characterized by papillary atrophy and concentrating defects (5, 15, 32, 35) . Utilization of a cryptic capacity for renin expression in derivatives of the collecting duct anlagen may be necessary for normal development of the renal medulla.
The unexpectedly widespread activity of the human renin promoter driving Cre in the vasculature (9, 18) and, according to our data, in the developing collecting duct system of the embryonic kidney may hamper attempts to inactivate floxed targets specifically in juxtaglomerular granular cells. This issue might be circumvented by the use of inducible Cre-transgenes under the control of the renin promoter. In this setting Cre expression would be induced in the adult mouse and, according to our data, might then be more restricted to juxtaglomerular granular cells.
Extrarenal expression of Cre recombinase reflecting the activity of the human renin promoter was at the detection limit in the adult mouse. However, in the embryo, substantial activity of the human renin promoter was observed in the cortex of the adrenal gland, as has been described for embryonic mice (10, 25) , sheep (34) and humans (3, 24) .
The activity of the human renin promoter in the embryonic brain and in cartilages seen in our transgenic model was also described previously for mice, rats, and humans (3, 24, 25, 27) .
In summary, we generated transgenic mice expressing Cre recombinase under the control of a 12. Single β-gal-positive cells were also observed in the glomerular mesangium (arrow in C).
Intense β-gal staining was found in the collecting duct system (E, F). Co-staining with anti-aquaporin-2 was used to confirm localization of β-gal staining in cells of the collecting duct (G). Note that many but not all of the aquaporin-2 positive cells also stain 25 for β-gal, indicating that Cre-mediated removal of the stop cassette in the reporter strain does not have 100% efficiency. No β-gal background staining was observed in kidneys from Cre-negative ROSA26-lacZ reporter mice (H, I). 
